CAPRICOR THERAPEUTICS, INC. (CAPR)
Capricor to Present Positive Five-Year HOPE-2 OLE Data and HOPE-3 Phase 3 Results for Deramiocel in Duchenne Muscular Dystrophy at PPMD 2026 Annual Conference
Capricor to Present Positive Five-Year HOPE-2 OLE Data and HOPE-3 Phase 3 Results for Deramiocel in Duchenne Muscular Dystrophy at PPMD 2026 Annual Conference
Novo Nordisk to showcase new data across its haemophilia portfolio at the ISTH Congress 2026, featuring investigational denecimig
RoboStrategy, Inc. Raises Approximately $36.5 Million Through Private Share Issuances
ICE First Look at Mortgage Performance: Mortgage Performance Holds Steady Despite Calendar-Driven Rise in Delinquencies
Superior Plus Announces Timing of 2026 Second Quarter Results Conference Call and Webcast
Seize the Multi-Billion-Yuan Childrens AI Market: Jinxin Technology Holding Company Unlocks Long-Term Revenue Growth Potential
Hemab Therapeutics to Present Clinical and Preclinical Data from Multiple Blood Coagulation Programs at the ISTH 2026 Congress
Star Therapeutics to Present Complete Data from Phase 1/2 Multidose Study of VGA039 in Von Willebrand Disease at ISTH 2026 Congress
SB Financial Group, Inc. Announces Schedule for Second Quarter 2026 Results
Native Shakes Up the Body Care Category with New Detoxifying Body Scrub Collection